DV

Dhaval Vasantbhai Shah

Active Director Designated Partner DIN 09115877
DIN 09115877 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Dhaval Vasantbhai Shah

Data last updated:

Dhaval Vasantbhai Shah is a Designated Partner at Vibrawn Medicare Llp (since 2021). The company operates in Pharma.

DIN 09115877
Primary Designation Designated Partner
Industry Pharma
First Appointment 20 Mar 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Mar 20212021Active

Board colleagues of Dhaval Vasantbhai Shah

NameDINCompanyDesignation
Dhrumil Kalidas Shah09092799Vibrawn Medicare LlpDesignated Partner
Kaushik Ranvirsinh Desai09092758Vibrawn Medicare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Vibrawn Medicare Llp
Premium access

Shareholding and investment profile for Dhaval Vasantbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhaval Vasantbhai Shah

Dhaval Vasantbhai Shah currently holds 1 directorship: Vibrawn Medicare Llp (Designated Partner, since 20 Mar 2021).

Dhaval Vasantbhai Shah was first appointed on 20 Mar 2021 as Designated Partner at Vibrawn Medicare Llp.

The current boards of Dhaval Vasantbhai Shah's companies include Dhrumil Kalidas Shah (Vibrawn Medicare Llp), Kaushik Ranvirsinh Desai (Vibrawn Medicare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available